Early Identification of the Association Between Rofecoxib and Cardiovascular Adverse Events Using real-World Data from the UK: A Case-Control Study

被引：0
|
作者：
Moslemzadeh, Donya [1 ]
Abtahi, Shahab [2 ]
Souverein, Patrick C. [2 ]
Heerdink, Eibert Rob [2 ]
Klungel, Olaf H. [2 ]
机构：
[1] Univ Utrecht, Utrecht, Netherlands
[2] Univ Utrecht, Utrecht Inst Pharmaceut Sci, Div Pharmacoepidemiol & Clin Pharmacol, Utrecht, Netherlands
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2024年 / 33卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
536
引用
收藏
页码：222 / 222
页数：1
相关论文
共 50 条
  • [21] Churn factors identification from real-world data in the telecommunications industry: case study
    Sulikowski, Piotr
    Zdziebko, Tomasz
    KNOWLEDGE-BASED AND INTELLIGENT INFORMATION & ENGINEERING SYSTEMS (KSE 2021), 2021, 192 : 4800 - 4809
  • [22] Lack of Association of Tegaserod With Adverse Cardiovascular Outcomes in a Matched Case-Control Study
    Anderson, Jeffrey L.
    May, Heidi T.
    Bair, Tami L.
    Muhlestein, Joseph B.
    Horne, Benjamin D.
    Carlquist, John F.
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS, 2009, 14 (03) : 170 - 175
  • [23] Geriatrics on beers criteria medications at risk of adverse drug events using real-world data
    Shin, Hyunah
    Kim, Nanyeong
    Cha, Jaehun
    Kim, Grace Juyun
    Kim, Ju Han
    Kim, Jong-Yeup
    Lee, Suehyun
    INTERNATIONAL JOURNAL OF MEDICAL INFORMATICS, 2021, 154
  • [24] Assessment of adverse events of the novel cardiovascular drug vericiguat: a real-world pharmacovigilance study based on FAERS
    Rao, Jin
    Chen, Xiangyu
    Liu, Yudi
    Wang, Xuefu
    Cheng, Pengchao
    Wang, Zhinong
    EXPERT OPINION ON DRUG SAFETY, 2024, 23 (10) : 1317 - 1325
  • [25] Predictive Modeling of Drug-Related Adverse Events with Real-World Data: A Case Study of Linezolid Hematologic Outcomes
    Patel, Anu
    Doernberg, Sarah B.
    Zack, Travis
    Butte, Atul J.
    Radtke, Kendra K.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2024, 115 (04) : 847 - 859
  • [26] Prevalence of atherosclerotic cardiovascular disease and subsequent major adverse cardiovascular events in Alberta, Canada: A real-world evidence study
    Chen, Guanmin
    Farris, Megan S.
    Cowling, Tara
    Pinto, Lionel
    Rogoza, Raina M.
    MacKinnon, Erin
    Champsi, Salimah
    Anderson, Todd J.
    CLINICAL CARDIOLOGY, 2021, 44 (11) : 1613 - 1620
  • [27] Multimorbidity in Atherosclerotic Cardiovascular Disease and Its Associations With Adverse Cardiovascular Events and Healthcare Costs: A Real-World Evidence Study
    Dai, Dingwei
    Fernandes, Joaquim
    Sun, Xiaowu
    Lupton, Laura
    Payne, Vaughn W.
    Berk, Alexandra
    JOURNAL OF HEALTH ECONOMICS AND OUTCOMES RESEARCH, 2024, 11 (01): : 75 - 85
  • [28] From common to unreported: a real-world study of adverse events to duloxetine in the treatment of osteoarthritis
    Di, Jingkai
    Qi, Likun
    Liu, Lujia
    Xing, Xinglong
    Liu, Yaru
    Xiang, Chuan
    EXPERT OPINION ON DRUG SAFETY, 2024,
  • [29] Incidence of adverse cardiovascular events in patients with insomnia: A systematic review and meta-analysis of real-world data
    Ali, Eman
    Shaikh, Asim
    Yasmin, Farah
    Sughra, Fatima
    Sheikh, Ayesha
    Owais, Rabia
    Raheel, Hamna
    Virk, Hafeez Ul Hassan
    Mustapha, Jihad A.
    PLOS ONE, 2023, 18 (09):
  • [30] INCIDENCE OF ADVERSE CARDIOVASCULAR EVENTS IN PATIENTS WITH INSOMNIA: A SYSTEMATIC REVIEW AND META-ANALYSIS OF REAL-WORLD DATA
    Aamir, Muhammad
    Ali, Eman
    Shaikh, Asim
    Sheikh, Ayesha
    Owais, Rabia
    Yasmin, Farah
    Abbas, Fatima Sughra
    Waqas, Muhammad A.
    Vyas, Apurva Vijay
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 81 (08) : 1680 - 1680
12345